Quinlan Paul T. - 13 Mar 2024 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Signature
/s/ Paul Quinlan
Issuer symbol
N/A
Transactions as of
13 Mar 2024
Net transactions value
+$329,991
Form type
4
Filing time
15 Mar 2024, 16:02:17 UTC
Previous filing
26 Jan 2024
Next filing
22 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBAY Common Stock Options Exercise $329,991 +41,824 +147% $7.89 70,262 13 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -41,824 -82% $0.000000 8,872 13 Mar 2024 Common Stock 41,824 $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant vests as to 1/4 of the underlying shares on October 12, 2021 and as to 1/48 of the underlying shares monthly thereafter.